Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China
· Delayed Price · Currency is CNY 9.93
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002728 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 81.67 | 20.5 | 253.18 | 178.2 | 126.92 | Upgrade
|
| Depreciation & Amortization | 69.82 | 64.37 | 60.1 | 52.52 | 51.31 | Upgrade
|
| Other Amortization | 0.01 | 0.05 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.07 | -0 | -0.12 | -0.04 | -0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.82 | 11.79 | 13.44 | 0.12 | 23.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.8 | -3.74 | -0.36 | -0.34 | -6.31 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.27 | -0.04 | 0.07 | 0.6 | 0.1 | Upgrade
|
| Other Operating Activities | 4.73 | 5.95 | 16.32 | 30 | 31.27 | Upgrade
|
| Change in Accounts Receivable | 45.81 | -42.92 | -8.02 | -34.02 | 13.98 | Upgrade
|
| Change in Inventory | 25.09 | 6.7 | -63.6 | -12.75 | 5.39 | Upgrade
|
| Change in Accounts Payable | 25.89 | -85.03 | -72.84 | 157.24 | 13.17 | Upgrade
|
| Change in Other Net Operating Assets | 0.17 | 0.72 | -0.81 | -1.76 | -1.1 | Upgrade
|
| Operating Cash Flow | 244.09 | -22.55 | 198.56 | 371.66 | 256.81 | Upgrade
|
| Operating Cash Flow Growth | - | - | -46.58% | 44.72% | 51.97% | Upgrade
|
| Capital Expenditures | -79.55 | -113.56 | -86.05 | -90.26 | -109.58 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.2 | 0.02 | 0.16 | 0.09 | 0.52 | Upgrade
|
| Investment in Securities | 600 | 1,784 | - | -13.5 | 250 | Upgrade
|
| Other Investing Activities | -809.2 | -1,780 | 0.36 | 0.34 | 6.31 | Upgrade
|
| Investing Cash Flow | -288.55 | -109.8 | -85.53 | -103.33 | 147.25 | Upgrade
|
| Short-Term Debt Issued | 618.95 | 1,014 | 626.63 | 763.45 | 432.86 | Upgrade
|
| Total Debt Issued | 618.95 | 1,014 | 626.63 | 763.45 | 432.86 | Upgrade
|
| Short-Term Debt Repaid | -889 | -809 | -965.88 | -517 | -836.12 | Upgrade
|
| Total Debt Repaid | -889 | -809 | -965.88 | -517 | -836.12 | Upgrade
|
| Net Debt Issued (Repaid) | -270.05 | 204.78 | -339.26 | 246.45 | -403.26 | Upgrade
|
| Issuance of Common Stock | 15.44 | 13.88 | 282.83 | - | 184.91 | Upgrade
|
| Repurchase of Common Stock | -7.34 | -93.86 | - | - | - | Upgrade
|
| Common Dividends Paid | -24.91 | -182.31 | -149.02 | -147.62 | -138.38 | Upgrade
|
| Other Financing Activities | 154 | -54 | 100 | -200 | - | Upgrade
|
| Financing Cash Flow | -132.86 | -111.51 | -105.44 | -101.17 | -356.73 | Upgrade
|
| Net Cash Flow | -177.33 | -243.85 | 7.59 | 167.16 | 47.33 | Upgrade
|
| Free Cash Flow | 164.54 | -136.11 | 112.51 | 281.39 | 147.24 | Upgrade
|
| Free Cash Flow Growth | - | - | -60.02% | 91.11% | 85.05% | Upgrade
|
| Free Cash Flow Margin | 17.80% | -19.79% | 10.54% | 31.74% | 19.42% | Upgrade
|
| Free Cash Flow Per Share | 0.32 | -0.27 | 0.24 | 0.64 | 0.37 | Upgrade
|
| Cash Income Tax Paid | 91.28 | 62.57 | 101.92 | 67.5 | 67.94 | Upgrade
|
| Levered Free Cash Flow | 121.09 | -148.47 | -14.32 | 175.85 | 60.27 | Upgrade
|
| Unlevered Free Cash Flow | 123.74 | -145.15 | -4.09 | 194.06 | 78.72 | Upgrade
|
| Change in Working Capital | 89.04 | -121.42 | -144.14 | 110.52 | 30.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.